1. Home
  2. CINGW vs MDBH Comparison

CINGW vs MDBH Comparison

Compare CINGW & MDBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CINGW
  • MDBH
  • Stock Information
  • Founded
  • CINGW N/A
  • MDBH 1997
  • Country
  • CINGW United States
  • MDBH United States
  • Employees
  • CINGW 13
  • MDBH N/A
  • Industry
  • CINGW Biotechnology: Pharmaceutical Preparations
  • MDBH
  • Sector
  • CINGW Health Care
  • MDBH
  • Exchange
  • CINGW Nasdaq
  • MDBH Nasdaq
  • Market Cap
  • CINGW N/A
  • MDBH 70.3M
  • IPO Year
  • CINGW 2021
  • MDBH 2023
  • Fundamental
  • Price
  • CINGW $0.06
  • MDBH $6.66
  • Analyst Decision
  • CINGW
  • MDBH
  • Analyst Count
  • CINGW 0
  • MDBH 0
  • Target Price
  • CINGW N/A
  • MDBH N/A
  • AVG Volume (30 Days)
  • CINGW N/A
  • MDBH 5.1K
  • Earning Date
  • CINGW N/A
  • MDBH 11-13-2024
  • Dividend Yield
  • CINGW N/A
  • MDBH N/A
  • EPS Growth
  • CINGW N/A
  • MDBH N/A
  • EPS
  • CINGW N/A
  • MDBH N/A
  • Revenue
  • CINGW N/A
  • MDBH $1,776,726.00
  • Revenue This Year
  • CINGW N/A
  • MDBH N/A
  • Revenue Next Year
  • CINGW N/A
  • MDBH N/A
  • P/E Ratio
  • CINGW N/A
  • MDBH N/A
  • Revenue Growth
  • CINGW N/A
  • MDBH N/A
  • 52 Week Low
  • CINGW N/A
  • MDBH $6.55
  • 52 Week High
  • CINGW N/A
  • MDBH $13.25
  • Technical
  • Relative Strength Index (RSI)
  • CINGW N/A
  • MDBH 28.48
  • Support Level
  • CINGW N/A
  • MDBH $6.55
  • Resistance Level
  • CINGW N/A
  • MDBH $7.40
  • Average True Range (ATR)
  • CINGW 0.00
  • MDBH 0.21
  • MACD
  • CINGW 0.00
  • MDBH -0.02
  • Stochastic Oscillator
  • CINGW 0.00
  • MDBH 23.57

About CINGW Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

About MDBH MDB Capital Holdings LLC common

MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.

Share on Social Networks: